| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10911200 | Lung Cancer | 2014 | 7 Pages |
Abstract
We found that the expression levels of RASSF3 were frequently downregulated in NSCLCs. Downregulation of RASSF3 strongly correlated with the progressive phenotypes of NSCLCs and EGFR wild-type status. In vitro studies also suggested that RASSF3 downregulation increases migration ability of lung cancer cells. Together, our findings indicate RASSF3 is a candidate tumor suppressor gene of NSCLCs.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Asuki Fukatsu, Futoshi Ishiguro, Ichidai Tanaka, Takumi Kudo, Kentaro Nakagawa, Keiko Shinjo, Yutaka Kondo, Makiko Fujii, Yoshinori Hasegawa, Kenji Tomizawa, Tetsuya Mitsudomi, Hirotaka Osada, Yutaka Hata, Yoshitaka Sekido,